ECR Publication Prizes for outstanding research
Congratulations to three Monash Biomedicine Discovery Institute (BDI) early career researchers (ECRs) who have been recognised with Faculty of Medicine Nursing and Health Sciences’ ECR Publication Prizes. This year, eight prizes were awarded to ECRs who have published an outstanding piece of research.
Dr Timothy Tucey, from the Traven lab, was awarded the Robert Porter Early Career Researcher Publication Prize for Laboratory Based Sciences for his Cell Metabolism publication titled ‘Glucose homeostasis is important for immune cell viability during Candida challenge and host survival of systemic fungal infection’.
“Receiving an ECR Publication Prize is a tremendous honour. I am grateful to all of my collaborators who worked together so effectively across multiple research platforms and institutes to allow this to happen,” Dr Tucey said.
“I started my project with a simple question: how does the fungal pathogen Candida albicans evade and kill macrophages? It took an exhaustive search, but with each experiment, additional pieces of the puzzle started fitting together and it became apparent that something remarkable was happening with regards to glucose metabolism in both host and pathogen. This study is a great example of how curiosity driven research can inform future, metabolism-based strategies for infection control,” he said.
Dr Shane Landry, from the Edwards lab, received the Henry Krum Early Career Researcher Publication Prize for Clinical Sciences for his paper published in Sleep, titled ‘Ventilatory control sensitivity in patients with obstructive sleep apnea is sleep stage dependent’.
“This work significantly improves our understanding of how ventilatory control changes during sleep and how these physiological changes contribute to the pathogenesis of obstructive sleep apnea,” Dr Landry said.
“I would like to acknowledge work and efforts of all of the co-authors, without whom this publication would not have been possible. I will use the awarded funds to support an ongoing RCT investigating the use of pharmacotherapies, targetted at resolving ventilatory control instability, to treat obstructive sleep apnea,” he said.
Dr Mitchell Lawrence, from the Risbridger lab, won the Early Career Researcher Fellows Publication Prize for Laboratory Based Research for his European Urology paper titled ‘Patient-derived models of abiraterone- and enzalutamide-resistant prostate cancer reveal sensitivity to ribosome-directed therapy’.
“I am honoured to receive the Fellows Publication Prize for Laboratory Sciences as part of a multidisciplinary team of 50 co-authors,” Dr Lawrence said.
“In this study, we transformed samples of patient tissue into new preclinical models of prostate cancer. Using these samples, we identified promising new treatments for aggressive tumours. I thank the patients who generously donated their tissue to our research program, the patient advocates who advised us on this study, and the funding bodies that supported us,” he said.
About the Monash Biomedicine Discovery Institute
Committed to making the discoveries that will relieve the future burden of disease, the newly established Monash Biomedicine Discovery Institute at Monash University brings together more than 120 internationally-renowned research teams. Our researchers are supported by world-class technology and infrastructure, and partner with industry, clinicians and researchers internationally to enhance lives through discovery.